Diabeloop develops disruptive technological innovations for diabetes treatment.

Originating from a French artificial pancreas research program, the DBLG1™ System is a self-learning device that embeds AI to better serve patients.

icon Created with Sketch.

DBLG1™ System

DGLB1™ System is an external medical device that connects 3 components: a continuous glucose monitor (CGM), a patch insulin pump and a locked-down handset hosting Diabeloop algorithm and user interface.

How does it work? Every 5 minutes, a glucose measurement is transmitted via Bluetooth technology to the handset. DBLG1 artificial intelligence analyzes data in real time and takes into account the patient’s physiology, history and data entries (meals or exercise) to determine the correct dose of insulin to administer. That’s what we call a hybrid closed-loop system.

icon Created with Sketch.